Noelle Huskey Mullin, BA

University of California, San Francisco
email: none

Grants

Targeting Breast Tumor Stem Cells with Cell Cycle Inhibitors 2010 (Cycle 16)
Dissertation 16GB-0054 $75,981


CDK1 Inhibition Targets the p53-NOXA-MCL1 Axis, Selectively Kills Embryonic Stem Cells, and Prevents Teratoma Formation
  Periodical: Stem Cell Reports
  Author(s): Huskey, N.E., Guo T., Evason K.J., Momcilovic O., Pardo, D., et al.
  Yr: 2015 Vol: 4 Nbr: Pgs: 374-89
  Associated Grant: Targeting Breast Tumor Stem Cells with Cell Cycle Inhibitors
 
MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition.
  Periodical: Journal of Experimental Medicine
  Author(s): Horiuchi D, Kusdra L, Huskey NE, et al, and Goga A
  Yr: 2012 Vol: 209 Nbr: 4 Pgs: 679-96
  Associated Grant: Targeting Breast Tumor Stem Cells with Cell Cycle Inhibitors
 
Chemical-genetic analysis of cyclin dependent kinase 2 function reveals an important role in cellular transformation by multiple oncogenic pathways.
  Periodical: Proceedings of the National Academy of Sciences of the United States of America
  Author(s): Horiuchi D, Huskey NE, Kusdra L, et al, and Goga A
  Yr: 2012 Vol: 109 Nbr: 17 Pgs: E1019-27
  Associated Grant: Targeting Breast Tumor Stem Cells with Cell Cycle Inhibitors
 
Discovery and Optimization of Sulfonyl Acrylonitriles as Selective, Covalent Inhibitors of Protein Phosphatase Methylesterase-1.
  Periodical: Journal of Medicinal Chemistry
  Author(s): Bachovchin DA, Zuhl AM, Speers AE, Wolfe MR, Weerapana E, Brown SJ, Rosen H, Cravatt BF
  Yr: Vol: Nbr: Pgs:
  Associated Grant: Targeting Breast Tumor Stem Cells with Cell Cycle Inhibitors
 
Academic cross-fertilization by public screening yields a remarkable class of protein phosphatase methylesterase-1 inhibitors.
  Periodical: Proceedings of the National Academy of Sciences of the United States of America
  Author(s): Bachovchin DA, Mohr JT, Speers AE, Wang C, Berlin JM et al and Cravatt B
  Yr: Vol: 108 Nbr: 17 Pgs: 6811-6816
  Associated Grant: Targeting Breast Tumor Stem Cells with Cell Cycle Inhibitors